31 mei 2005: Bron: World J Gastroenterol. 2005 Jan 21;11(3):439-42.

Fuzheng Yiliu decoction - een Chinees kruid - als aanvulling verhoogt significant de effectiviteit van chemo bij maagkanker en vermindert significant de bijwerkingen, ook op het beenmerg en de spijsvertering en verbetert daarmee de kwaliteit van leven en verbetert tegelijkertijd de cel immuniteit in vergelijking met de controlegroep die alleen chemo kreeg. Dit blijkt uit kleine maar wel gerandomiseerde studie met 60 maagkankerpatiënten

Effect of Fuzheng Yiliu decoction combined with chemotherapy on patients with intermediate and late stage gastrointestinal cancer.

Pan B, Cheng T, Nan KJ, Qiu GQ, Sun XC.
Department of Physiology, School of Medicine, Xi'an Jiaotong University, Xi'an 710061, Shaanxi Province, China. binpan@vip.sina.com

AIM: To investigate the therapeutic effects of Fuzheng Yiliu (strengthening the body resistance to inhibit tumor) decoction combined with chemotherapy on the patients with intermediate and late stage gastrointestinal cancer.

METHODS: Sixty patients were randomly divided into treatment group (chemotherapy combined with Fuzheng Yiliu decoction) and control group (chemotherapy alone). Four indexes, including the tumor recent remission rate (RR), the change of main symptoms, the toxic and side effects caused by chemotherapy and the change of performance status, were observed in the patients. Peripheral blood contents of CD3+, CD4+, CD8+ cells, CD4+/CD8+ and soluble interleukin-2 receptor (sIL-2R) were tested before and after treatment and the values were compared with those of healthy peoples.

RESULTS: The improving rate of main symptoms (69.6%) and performance status (56.7%) were significantly higher in the treatment group than in the control group (34.8%, 26.7%, P<0.05). The occurrence rates of grade II toxic and side-effects on both bone marrow (13.3%) and digestive tract (30%) were lower in the treatment group compared to the control group (36.7%, 63.3%, P<0.05). Before treatment, the proportion of CD3+, CD4+ and CD4+/CD8+ decreased and the proportion of CD8+ and sIL-2R raised markedly both in the control group and treatment group as compared to the healthy people. After treatment, that increased of CD3+, CD4+, CD4+/CD8+ increased (62.25+/-10.01% vs 68.31+/-9.72%, 36.83+/-10.44% vs 42.6+/-9.62%, 1.24+/-0.65 vs 1.66+/-0.85, P<0.05) and the values of CD8+ and sIL-2R decreased obviously (33.06+/-7.69% vs 29.24+/-6.25%, 588.23+/-216.86 U/mL vs 475.87+/-211.36 U/mL, P<0.05) in the treatment group, whereas these values were opposite in the control group (64.22+/-6.91% vs 60.63+/-5.75%, 35.62+/-7.49% vs 31.53+/-5.53%, 32.95+/-8.28% vs 37.14+/-7.48%, 1.17+/-0.43 vs 0.94+/-0.43, 573.63+/-214.32 U/mL vs 692.17+/-221.33 U/mL, P<0.05).

CONCLUSION: Fuzheng Yiliu decoction can enhance therapeutic effects of chemotherapy on malignant gastrointestinal tumor, and also reduce the toxic and side effects on bone marrow and digestive tract, thereby improving the quality of life and cellular immunity in patients with malignant gastrointestinal tumor.

Publication Types:
Clinical Trial
Randomized Controlled Trial

PMID: 15637764 [PubMed - indexed for MEDLINE]

Plaats een reactie ...

Reageer op "Chinese kruiden en effect bij maagkanker: Fuzheng Yiliu decoction - een Chinees kruid - als aanvulling verhoogt significant de effectiviteit van chemo bij maagkanker en vermindert significant de bijwerkingen en verbetert sterk kwaliteit van leven"


Gerelateerde artikelen
 

Gerelateerde artikelen

Studiepublicaties van voeding, >> Arginine aanvullend op enterale >> Arginine plus omega-3-vetzuren >> Broccoli en broccolispruiten >> Chinese kruiden: Behandeling >> Chinese kruiden en effect >> Cranberrysap remt groei en >> Hyperthermie en chemo tijdens >> Lentinan, een paddenstoelextract >> Lentinan (Shitake) geeft uitstekende >>